PJSC SIC Borshchahivskiy Chemical Pharmaceutical Plant (BCPP, Kyiv) may obtain a license to produce baby food and dietary food products.
As the company reported in the information disclosure system of the National Securities and Stock Market Commission (NSSMC), the issue of obtaining such licenses at the initiative of shareholder Aletber Limited (Cyprus) is on the agenda of the shareholders’ meeting to be held on April 30.
By the end of 2023, BCPP increased production by 17.6% compared to 2022 to almost UAH 1.866 billion, but in physical terms it decreased by 3.3% to 34.8 million packs. At the same time, 40.3 million packs were sold last year, which is 7.8% less than in 2022, while total sales increased by 16.5% to UAH 1.806 billion.
In 2023, BCPP’s net profit increased by 3.38% compared to 2022 to UAH 262.863 million.
As of the first quarter of 2023, 31.8% of BCPP shares were owned by the pharmaceutical company Pharmaceutical Firm “Darnitsa” (Kyiv).
According to the Opendatabot system, the ultimate beneficiaries of BCPP are also the beneficiary of the pharmaceutical company “Darnitsa” Hlib Zagoriy, Yevhen Sova and Tetiana Artemenko.
